GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
3.660
-0.020 (-0.54%)
Aug 10, 2026, 4:00 PM EDT - Market closed

GoodRx Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
785.23796.85792.32750.27766.55745.42
Revenue Growth
-1.83%0.57%5.61%-2.13%2.83%35.36%
Cost of Revenue
72.0457.648.2266.9365.0846.72
Gross Profit
713.19739.26744.11683.34701.48698.71
Selling, General & Admin
432.77445.52484.98466.84502.42524.9
Depreciation & Amortization Expenses
88.6485.2269.54107.6754.1834.54
Research & Development
116.84121.03123.75135.84143.14125.86
Total Operating Expenses
638.25651.76678.26710.35699.74685.3
Operating Income
74.9487.4965.85-27.011.7413.41
Interest Income
6.6110.9323.2732.179.270.06
Interest Expense
-40.81-42.61-52.92-56.73-34.24-23.64
Other Non-Operating Income (Expense)
0.650.72-4.74-4.01--
Total Non-Operating Income (Expense)
33.5530.9534.3928.5724.9723.58
Pretax Income
41.456.5431.46-55.57-23.23-10.18
Provision for Income Taxes
25.1526.115.07-46.79.615.08
Net Income
16.2530.4416.39-8.87-32.83-25.25
Net Income to Common
16.2530.4416.39-8.87-32.83-25.25
Net Income Growth
-53.04%85.72%----
Shares Outstanding (Basic)
342356386410413410
Shares Outstanding (Diluted)
345357392410413410
Shares Change
-8.67%-8.97%-4.42%-0.62%0.70%49.25%
EPS (Basic)
0.050.090.04-0.02-0.08-0.06
EPS (Diluted)
0.040.090.04-0.02-0.08-0.06
EPS Growth
-60.00%125.00%----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
197.09164.38182.65137.25142.81174.21
Free Cash Flow Growth
4.01%-10.00%33.08%-3.90%-18.02%57.24%
Free Cash Flow Per Share
0.570.460.470.330.350.42
Gross Margin
90.83%92.77%93.91%91.08%91.51%93.73%
Operating Margin
9.54%10.98%8.31%-3.60%0.23%1.80%
Profit Margin
2.07%3.82%2.07%-1.18%-4.28%-3.39%
FCF Margin
25.10%20.63%23.05%18.29%18.63%23.37%
EBITDA
163.58172.71135.3880.6655.9247.95
EBITDA Margin
20.83%21.67%17.09%10.75%7.29%6.43%
EBIT
74.9487.4965.85-27.011.7413.41
EBIT Margin
9.54%10.98%8.31%-3.60%0.23%1.80%
Effective Tax Rate
60.75%46.16%47.90%84.04%-41.31%-148.15%
SEC Filings: 10-K · 10-Q